Form 4: Sotera Health Director Ann R. Klee Sells 5,750 Shares in Public Offering

Director Ann R. Klee sold 5,750 shares of Sotera Health (SHC) at $14.3075 per share as part of a public secondary offering.

Summary

• On March 4, 2024, Ann R. Klee, a director of Sotera Health Co [SHC], sold 5,750 shares of common stock.
• The sale was part of an underwritten public secondary offering.
• The price per share was $14.3075, reflecting the offering price less underwriting discounts and commissions.
• Following the transaction, Klee directly owns 86,735 shares, including vested and unvested common stock and restricted stock units.
• The unvested shares will vest daily through May 27, 2025.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by an insider. The sentiment is neutral as it simply reports a sale of shares.

Industry Context

Sales by insiders are a common occurrence, especially following a secondary offering. It's important to consider the overall context of insider transactions and company performance.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some investors, potentially leading to short-term price fluctuations.
• However, the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding shares.

Key Dates